Scientific articles index
Filters: Author is Robyn J. Barst, MD [Clear All Filters]
"REVEAL Registry: Baseline Characteristics of the First 1226 Enrolled Patients.". In: 2008 Scientific Sessions at PHA International PH Conference.; 2008.
"Ambulatory right ventricular and pulmonary artery pressure response to treatment with bosentan and treprostinil in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
"TOPP: The First Multinational Registry in Pediatric Pulmonary Hypertension.". In: 2008 Scientific Sessions at PHA International PH Conference.; 2008.
"Relation Between Pulmonary Arterial Pressure Response and Exercise Tolerance in Pulmonary Arterial Hypertension Patients Treated with Bosentan or Treprostinil .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Pulmonary Hypertension Roundtable. Advances in Pulmonary Hypertension. 2003;2(2):20-25.
"Hemodynamic response during six-minute walk tests and during daily living in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
Pulmonary Hypertension Roundtable. Advances in Pulmonary Hypertension. 2007;6(3):142-148.
CME Self-Assessment Examination. Advances in Pulmonary Hypertension. 2009;8(2):87-88.
"Clinical Science Delivery of Intravenous Treprostinil at Low Infusion Rates Using a Miniaturized Infusion Pump in Patients with Pulmonary Arterial Hypertension.". In: 2008 Scientific Sessions at PHA International PH Conference.; 2006.
"Acute Vasoreactivity and Genetic Polymorphisms in IPAH/FPAH Children and Adults.". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
"REVEAL Registry: Baseline Characteristics of Patients with Childhood-Onset PAH.". In: 2008 Scientific Sessions at PHA International PH Conference.; 2008.
"Congenital Heart Disease.". In: 2005 PH Resource Network Symposium.; 2005.
"Ambulatory right ventricular and pulmonary artery pressure response to treatment with bosentan and treprostinil in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
"Hemodynamic response during six-minute walk tests and during daily living in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
"Relation Between Pulmonary Arterial Pressure Response and Exercise Tolerance in Pulmonary Arterial Hypertension Patients Treated with Bosentan or Treprostinil .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
"Hemodynamic response during six-minute walk tests and during daily living in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
"One Year Experience with Intravenous Treprostinil in Pulmonary Arterial Hypertension (PAH) Patients.". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
"Ambulatory right ventricular and pulmonary artery pressure response to treatment with bosentan and treprostinil in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
"Hemodynamic response during six-minute walk tests and during daily living in patients with pulmonary arterial hypertension .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
"Relation Between Pulmonary Arterial Pressure Response and Exercise Tolerance in Pulmonary Arterial Hypertension Patients Treated with Bosentan or Treprostinil .". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
"Pulmonary Hypertension in Children with Sickle Cell Disease.". In: 2006 Scientific Sessions at PHA International PH Conference.; 2006.
]